Patents by Inventor Tatsuya Miyazawa
Tatsuya Miyazawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11989950Abstract: An information processing apparatus includes a first detection unit which detects an object around a vehicle, a second detection unit of which at least a part of a detection range overlaps a detection range of the first detection unit and which detects an object around the vehicle, and a determination unit which determines whether or not the object has started to move on the basis of detection results of the first detection unit and the second detection unit. The determination unit determines that the object has started to move in a case in which the vehicle and the object are in a halted state when a detection result of the first detection unit indicates that the object has started to move and a detection result of the second detection unit indicates that the object has started to move.Type: GrantFiled: September 18, 2020Date of Patent: May 21, 2024Assignee: HONDA MOTOR CO., LTD.Inventors: Tatsuya Konishi, Katsunori Miyazawa, Kenta Ishii
-
Patent number: 11466272Abstract: The present invention provides a double-stranded nucleic acid consisting of a sense-strand nucleic acid and an antisense-strand nucleic acid and comprising a double-strand region having at least 11 base pairs, for suppressing expression of APCS gene, in which an oligonucleotide chain having a chain length of at least 17 nucleotides and at most 30 nucleotides in the antisense-strand nucleic acid is complementary to a target APCS mRNA sequence comprising a base sequence set forth in any one of SEQ ID NOS: 1288 to 1930.Type: GrantFiled: May 31, 2018Date of Patent: October 11, 2022Assignee: KYOWA KIRIN CO., LTD.Inventors: Hiroyuki Ariyama, Takuya Murakami, Takashi Imaeda, Tatsuya Miyazawa
-
Publication number: 20200190514Abstract: The present invention provides a double-stranded nucleic acid consisting of a sense-strand nucleic acid and an antisense-strand nucleic acid and comprising a double-strand region having at least 11 base pairs, for suppressing expression of APCS gene, in which an oligonucleotide chain having a chain length of at least 17 nucleotides and at most 30 nucleotides in the antisense-strand nucleic acid is complementary to a target APCS mRNA sequence comprising a base sequence set forth in any one of SEQ ID NOS: 1288 to 1930.Type: ApplicationFiled: May 31, 2018Publication date: June 18, 2020Applicant: KYOWA KIRIN CO., LTD.Inventors: Hiroyuki ARIYAMA, Takuya MURAKAMI, Takashi IMAEDA, Tatsuya MIYAZAWA
-
Publication number: 20200056177Abstract: The present invention provides a novel long non-coding RNA (lncRNA), which is induced by ?-catenin and highly expressed in cancer, a nucleic acid that suppresses expression of the lncRNA, a means for promoting or suppressing cell growth by using the lncRNA or the nucleic acid, and the like.Type: ApplicationFiled: June 14, 2019Publication date: February 20, 2020Applicant: THE UNIVERSITY OF TOKYOInventors: Hiroyuki ABURATANI, Aya NONAKA, Tatsuya MIYAZAWA, Tetsuo YOSHIDA
-
Patent number: 9676025Abstract: Provided is a low-pressure casting apparatus for stable casting without using feedback control even if a furnace body has a crack, and a low-pressure casting method using the same. A low-pressure casting apparatus fills a cavity with molten metal M through a guiding unit by introducing gas into a holding furnace for heating the molten metal M to apply pressure to a surface of the molten metal M. The holding furnace includes a casing, a furnace body accommodated in the casing, and a refractory layer disposed between the casing and the furnace body, the refractory layer having a pore structure. The low-pressure casting apparatus further includes a first gas supply unit for supplying to the furnace body the gas to apply pressure to the molten metal M and a second gas supply unit for supplying gas to the refractory layer.Type: GrantFiled: January 28, 2016Date of Patent: June 13, 2017Assignee: HONDA MOTOR CO., LTD.Inventors: Nobutaka Tsutsumi, Tatsuya Miyazawa, Hiroshi Takahashi, Shinsuke Fujiyama
-
Patent number: 9617538Abstract: There is provided a heptamer-type small guide nucleic acid that comprises any of the 7-base sequences of SEQ ID NOS: 1 to 15, and induces apoptosis of human leukemia cells. A leukemia therapeutic agent containing the heptamer-type small guide nucleic acid as an active ingredient is also provided. The novel heptamer-type sg nucleic acid can induce apoptosis of human leukemia cells.Type: GrantFiled: August 24, 2012Date of Patent: April 11, 2017Assignees: NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCE, NIIGATA UNIVERSITYInventors: Masayuki Nashimoto, Masuhiro Takahashi, Miwako Narita, Tetsuo Yoshida, Tatsuya Miyazawa
-
Publication number: 20160221075Abstract: Provided is a low-pressure casting apparatus for stable casting without using feedback control even if a furnace body has a crack, and a low-pressure casting method using the same. A low-pressure casting apparatus fills a cavity with molten metal M through a guiding unit by introducing gas into a holding furnace for heating the molten metal M to apply pressure to a surface of the molten metal M. The holding furnace includes a casing, a furnace body accommodated in the casing, and a refractory layer disposed between the casing and the furnace body, the refractory layer having a pore structure. The low-pressure casting apparatus further includes a first gas supply unit for supplying to the furnace body the gas to apply pressure to the molten metal M and a second gas supply unit for supplying gas to the refractory layer.Type: ApplicationFiled: January 28, 2016Publication date: August 4, 2016Inventors: Nobutaka Tsutsumi, Tatsuya Miyazawa, Hiroshi Takahashi, Shinsuke Fujiyama
-
Publication number: 20150329858Abstract: The present invention provides a novel long non-coding RNA (lncRNA), which is induced by ?-catenin and highly expressed in cancer, a nucleic acid that suppresses expression of the lncRNA, a means for promoting or suppressing cell growth by using the lncRNA or the nucleic acid, and the like.Type: ApplicationFiled: November 15, 2013Publication date: November 19, 2015Inventors: Hiroyuki ABURATANI, Aya NONAKA, Tatsuya MIYAZAWA, Tetsuo YOSHIDA
-
Publication number: 20150025232Abstract: There is provided a heptamer-type small guide nucleic acid that comprises any of the 7-base sequences of SEQ ID NOS: 1 to 15, and induces apoptosis of human leukemia cells. A leukemia therapeutic agent containing the heptamer-type small guide nucleic acid as an active ingredient is also provided. The novel heptamer-type sg nucleic acid can induce apoptosis of human leukemia cells.Type: ApplicationFiled: August 24, 2012Publication date: January 22, 2015Inventors: Masayuki Nashimoto, Masuhiro Takahashi, Miwako Narita, Tetsuo Yoshida, Tatsuya Miyazawa
-
Publication number: 20110130442Abstract: Provided are a mast cell degranulation control agent, a diagnostic agent or therapeutic agent for a disease resulting from mast cell degranulation control, a method of controlling mast cell degranulation, and a screening method for a mast cell degranulation control agent, all of which involve the use of a nucleic acid and the like. These are useful in the diagnosis or treatment of a disease resulting from mast cell degranulation control.Type: ApplicationFiled: June 4, 2009Publication date: June 2, 2011Applicant: KYOWA HAKKO KIRIN CO., LTD.Inventors: Kyoko Kosaka, Yoji Yamada, Kazumi Miura, Tatsuya Miyazawa, Tetsuo Yoshida
-
Publication number: 20110021600Abstract: According to the present invention, it possible to provide a novel nucleic acid, a vector that expresses the nucleic acid, a screening method for a substance that controls the nucleic acid, a method of detecting the expression and a mutation of the nucleic acid, and a diagnostic method or therapeutic method for a disease caused by an abnormality of mesenchymal stem cells, mast cells or the like, or a disease caused by a cell proliferation abnormality, such as cancer.Type: ApplicationFiled: September 4, 2007Publication date: January 27, 2011Applicant: KYOWA HAKKO KIRIN CO., LTD.Inventors: Yoji Yamada, Tatsuya Miyazawa, Tetsuo Yoshida, Haruo Nakano, Kyoko Kosaka
-
Publication number: 20100305188Abstract: Provided are an agent for suppressing or promoting cell proliferation, a diagnostic reagent or therapeutic drug for a disease resulting from a cell proliferation abnormality, an agent for inducing apoptosis, an agent for suppressing or promoting the expression of a target gene for a nucleic acid such as a microRNA, and a method of suppressing or promoting cell proliferation.Type: ApplicationFiled: October 3, 2008Publication date: December 2, 2010Applicant: KYOWA HAKKO KIRIN CO., LTD.Inventors: Haruo Nakano, Tatsuya Miyazawa, Yoji Yamada, Tetsuo Yoshida
-
Publication number: 20100099746Abstract: The present invention provides a nucleic acid such as a micro-RNA or a micro-RNA precursor, having a novel sequence. The nucleic acid of the present invention is useful for detecting the expression or a mutation of a micro-RNA, separating cells, suppressing the expression of a gene having a target sequence, screening for a substance that promotes or suppresses a function of a micro-RNA, and diagnosing or treating a disease caused by a mast cell abnormality, a disease caused by an abnormality of mesenchymal stem cell proliferation or differentiation, cancers, and a disease caused by abnormal proliferation of cells, tissue hyperplasia or the like.Type: ApplicationFiled: December 18, 2007Publication date: April 22, 2010Applicant: KYOWA HAKKO KIRIN CO., LTD.Inventors: Yoji Yamada, Tatsuya Miyazawa, Tetsuo Yoshida, Haruo Nakano, Kyoko Kosaka